2 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Fengxi Su: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China Breast Cancer | Unknown | Fengxi Su | 20000 | 2019-09-05 | 2019-09-03 | |
| Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients toremifene or tamoxifen - Breast Cancer Patients in Premenopausal, Estrogen and/or Progesterone Receptor Positive | Phase 2 / Phase 3 | Unknown | Fengxi Su | 3036 | 2014-04-01 | 2014-05-06 |
Breast Neoplasms (1)
Tamoxifen (1) · Toremifene (1)
China (2)
Musheng Zeng, MD (1) · Qianjun Chen, MD (1)